Journal
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
Volume 27, Issue 4, Pages 342-349Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.numecd.2016.12.010
Keywords
Dyslipidemia; Nutritional Therapy; Adolescents; PCSK9; Obesity
Funding
- National Institutes of Health [5K12DK094721-05, R01 DK094162, K23 HL085308]
- Harvard Catalyst
- Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health Award) [UL1 TR001102]
- Harvard University
- New Balance Foundation
- National Institute of Diabetes and Digestive and Kidney Diseases [K24 DK082730]
- Boston Children's Hospital
- Farb Family Fund
- Kostin Family Innovation Fund
Ask authors/readers for more resources
Background and aims: Nutritional therapy is the first line approach to treatment of hyperlipidemia in childhood. Proprotein convertase subtilisin kexin type 9 (PCSK9) is a key regulator of plasma cholesterol levels and a target of novel lipid-lowering pharmacotherapies. We examined the effects of an intensive nutritional intervention on PCSK9 levels in overweight adolescents with cardiovascular disease (CVD) risk factors. Methods and results: Twenty seven obese and overweight adolescents with CVD risk factors were assigned to either a low fat or low glycemic load diet. During an 8-week Intensive Phase,assigned meals were delivered to the home, and all participants received weekly in-person home nutrition counseling and phone calls. The subjects then underwent a 4-month Maintenance Phase without food provision and with no in-person contact. Anthropometric measurements, laboratory data, and serum PCSK9 protein levels were measured at baseline, 8 weeks, and 6 months. PCSK9 decreased by 16.5% at 8 weeks (201.2 +/- 56.3 vs 165.6 +/- 58.4 ng/mL; p < 0.001); PCSK9 levels returned to baseline levels at 6 months, after the Maintenance Phase. Change in PCSK9 was associated with change in fasting insulin, HOMA-IR, and AUC insulin, independent of weight loss. Conclusions: PCSK9 decreased in youth participating in an intensive dietary intervention. Change in HOMA-IR was associated with change in PCSK9, independent of weight loss, suggesting an important relationship with insulin sensitivity. (C) 2017 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available